Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ProQR Therapeutics N.V (PRQR) Long-Term Investments: 2021-2022

Historic Long-Term Investments for ProQR Therapeutics N.V (PRQR) over the last 2 years, with Dec 2022 value amounting to $633,574.

  • ProQR Therapeutics N.V's Long-Term Investments rose 2.05% to $676,222 in Q2 2023 from the same period last year, while for Jun 2023 it was $676,222, marking a year-over-year increase of 2.05%. This contributed to the annual value of $633,574 for FY2022, which is 6592.32% up from last year.
  • Per ProQR Therapeutics N.V's latest filing, its Long-Term Investments stood at $633,574 for FY2022, which was up 6,592.32% from $9,467 recorded in FY2021.
  • Over the past 5 years, ProQR Therapeutics N.V's Long-Term Investments peaked at $633,574 during FY2022, and registered a low of $9,467 during FY2021.
  • In the last 2 years, ProQR Therapeutics N.V's Long-Term Investments had a median value of $321,520 in 2021 and averaged $321,520.
  • Data for ProQR Therapeutics N.V's Long-Term Investments shows a peak YoY surged of 6,592.32% (in 2022) over the last 5 years.
  • Over the past 2 years, ProQR Therapeutics N.V's Long-Term Investments (Yearly) stood at $9,467 in 2021, then spiked by 6,592.32% to $633,574 in 2022.